Drug-drug interactions in pediatric psychopharmacology.
Serious consequences caused by drug-drug interactions continue to plague contemporary pharmacotherapy. The possibility of a drug-drug interaction should be suspected anytime a new or unexpected effect occurs that complicates the clinical management of a patient in the setting where the patient is receiving more than one drug. In this article, the authors address the mechanisms of pharmacokinetic-based drug-drug interactions focusing on important interactions that may occur with the common medications a pediatrician may prescribe to the child receiving psychoactive medication(s) prescribed by a child psychiatrist.
Ten Eick
A P
AP
Division of Pediatric Pharmacology and Critical Care, Rainbow Babies and Children's Hospital, Cleveland, Ohio, USA.
Nakamura
H
H
Reed
M D
MD
D000293:Adolescent; D001008:Anxiety Disorders / Q000188:drug therapy; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy; D002648:Child; D003866:Depressive Disorder / Q000188:drug therapy; D004347:Drug Interactions; D006801:Humans; D011600:Psychopharmacology; D011618:Psychotic Disorders / Q000188:drug therapy; D011619:Psychotropic Drugs / Q000145:classification / Q000378:metabolism / Q000493:pharmacokinetics* / Q000494:pharmacology*
D011619:Psychotropic Drugs